Sunday, 8th September, 2024
THE HERITAGE ISSUE
Glimpses into Ophthalmic Genius How trailblazing innovations are helping shape future advances.
STOP!
Glaucoma Disease Progression iStent technologies have been proven to stabilize visual fields loss and glaucoma disease progression with a favourable risk-benefit ratio1 ®
Join Our Experts Panel to learn more SCAN THE QR CODE TO
ACCESS THE FULL PROGRAM
2797
1. Gillmann K, Hombeak DM. BMJ Open Ophth 2024;9:e001575.doi:10.1136/bmjophth-2023-001575. Important Safety Information at https://www.glaukos.com/en-uk/ ©2024 Glaukos Corporation. Glaukos, iStent inject® and iStentinject® W are registered trademarks of Glaukos Corporation PM-EU-0317